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Introduction {#sec001}
============

*Pseudomonas aeruginosa* was ranked first among all antibiotic-resistant gram-negative strains according to the China National Antimicrobial Resistance Investigation Net annual report of 2011\[[@pone.0139995.ref001]\]. It was listed as one of the main pathogenic bacteria in nosocomial infection owing to its capacity to develop resistance to multiple classes of antimicrobials through intrinsic mechanisms and through the acquisition of transferable resistance determinants \[[@pone.0139995.ref002]\]. In spite of its resistance, *P*. *aeruginosa* continued to remain sensitive to carbapenems; imipenemis one of the most frequently used drugs for the treatment of *P*. *aeruginosa* infections in China. However, the accumulation of carbapenem-resistant mechanisms could probably further increase carbapenem MICs, leaving even fewer therapy options for clinicians against the multi-drug resistant *P*. *aeruginosa* \[[@pone.0139995.ref003]\]. Studies on the antimicrobial resistance in *P*. *aeruginosa* have been reported by the Chinese CHINET system; the resistance rates to imipenem and meropenem were 30.5% and 24.5% in 2008, 30.5% and 25.2% in 2009, and 30.8% and 25.8% in 2010, respectively \[[@pone.0139995.ref004]\]. Therefore, *P*. *aeruginosa* infections are now difficult to cure and have become life threatening.

OprD is a substrate-specific outer membrane porin of *P*. *aeruginosa*, which allows the diffusion of basic amino acids, small peptides, and imipenem into the cell \[[@pone.0139995.ref005]\]. For imipenem, OprD loss can push the MIC above the resistance breakpoint \[[@pone.0139995.ref006]\]. Most carbapenem-resistant *P*. *aeruginosa* strains are defective in expression of OprD\[[@pone.0139995.ref007]\]. Damien Fournier et al. have reported many types of mechanisms of CRPA, including the production of the spectrum β-lactamase or carbapenemases, over-expression of the efflux pump, and the loss of outer membrane porins, with porinOprD lost in 94(86.2%) of the strains in their study \[[@pone.0139995.ref008]\]. We believe that the loss of OprD may present the main mechanisms of carbapenem-resistance in *P*. *aeruginosa*.

In order to test this hypothesis regarding the contribution of the outer membrane protein OprD~2~to carbapenem-resistance in *P*. *aeruginosa*, the OprD~2~ genes were amplified and sequenced in the present study and the role of the protein in carbapenem resistance was analyzed.

Materials and Methods {#sec002}
=====================

Materials {#sec003}
---------

### Bacterial strains {#sec004}

We isolated 141 strains of *P*. *aeruginosa* with carbapenem-resistant (imipenem- or meropenem-bacteriostatic inhibition zones ≤13mm) from the First Affiliated Hospital of Anhui Medical University in China from January to December 2013. The quality control strain for the antimicrobial susceptibility test was ATCC 27853, and the strain PAO1 was employed as the standardized control for the analysis of the outer membrane protein OprD~2~ with SDS-PAGE electrophoresis.

### Antibiotics {#sec005}

Fourteen antimicrobial agents were tested: imipenem (IMP), meropenem (MEM), gentamycin (GEN), amikacin (AMK), ciprofloxacin (CIP), levofloxacin (LVX), piperacillin (PIP), cefotaximes (CTX), cefepime (FEP), cefoperazone (CFP), cefoperazone/Sulbactam (CLS), piperacillin/tazobactam (TZP), aztreonam (ATM), and polymyxin B (POL). All antimicrobials were produced by OXOID (Britain). Imipenem was purchased from Hangzhou Merck Pharmaceutical Co., Ltd. Meropenem is a standard drug approved by the Ministry of Health Biological Products in China.

### Medium and biochemical reagents {#sec006}

MH agar medium was purchased from OXOID. PCR detection reagents, buffers, Taqpolymerase, dNTPs, and the cloning Vector PMD18 carrier were obtained from Takara products (Dalian, China). Tris Base, glycine, acrylamide, N,N\'-methylenebis-acrylamide, N,N,N\',N\'-tetramethylethylenediamine (TEMED), sodium dodecyl sulfate (SDS), ammonium persulphate (AP), and Coomassie Brilliant Blue R250 were provided by Sangon Biomart Co. (Shanghai, China). Low molecular weight standard proteins (Marker) were purchased from Shanghai Sibas biotechnology. Phosphate-buffered saline (PBS) and decoloring liquid were prepared in our laboratory.

### Primers {#sec007}

The OprD primers (OprD-A: 5′-ATGAAAGTGATGAAGTGGAGCG--3′, OprD-B: 5′-TTACAGGATCGACAGCGGATAG--3′; fragment size: 1332bp) were designed according to the GenBank sequence (NC_002516) and synthesized by Shanghai Yingjun Biotechnology (Shanghai, China).

### Bioinformatics software {#sec008}

DNAstar software (U.S. DNAstar) was used to visualize DNA bands, and Quality One gel imaging analysis software (Bio-Rad) was employed to visualize protein bands after SDS-PAGE.

Methods {#sec009}
-------

### Antimicrobial susceptibility test {#sec010}

Susceptibility to 14 antibiotics was tested in all *P*. *aeruginosa* isolates using the K-B disk diffusion method following the guidelines of the Clinical and Laboratory Standards Institute (CLSI) \[[@pone.0139995.ref009]\]. In addition, the minimum inhibitory concentration (MIC) of imipenem and meropenem was determined using the agar dilution method. Imipenem and meropenem concentrations ranged from 0.06 to128 mg/L, and the bacterial inoculum size was 104 CFU/point. Susceptibility was interpreted according to CLSI breakpoints.

### PCR amplification of the OprD~2~-encoding gene sequence {#sec011}

Yoneyama et al.\[[@pone.0139995.ref010]\] have reported two kinds of deletion mutations: one type of mutant had an 11bp deletion in the 395--405coding region, the other contained a 1024bp deletion from nucleotides -519 to 685 at the initiation codon. Primers detecting full-length OprD~2~ were designed in this study, and the OprD~2~ -encoding gene was amplified by PCR. PCR products were analyzed by agarose gel electrophoresis, and three possible results were expected: 1.) TheOprD~2~ gene features mutations or lacks a small fragment of 11bp. The gene products can amplify the corresponding bands are visible, but in order to distinguish between small deletions and mutations further sequencing analysis would be required. 2.) The OprD~2~ gene contains 1024-bp fragment deletions, the corresponding DNA segment cannot be amplified, and the electrophoresis results are negative. 3.) The OprD~2~ contains insertions, the primers can amplify the corresponding DNA fragments, and electrophoresis results are positive. The PCR amplification products were sequenced by Sangon Biomart Co. (Shanghai, China). Nucleotide sequences were analyzed and compared by BLAST.

### Analysis of the outer membrane protein OprD~2~ {#sec012}

There were 15 imipenem-resistant and 3 imipenem-sensitive *P*. *aeruginosa* (including the control strain PAO1) that contained large fragment deletions, missing small fragments, or inserted genes. Potentially resulting changes in the OprD~2~ outer membrane protein were analyzed in these strains using SDS-PAGE. The preparation of outer membrane proteins and SDS-PAGE were performed according to previously described methods\[[@pone.0139995.ref011],[@pone.0139995.ref012]\]. After electrophoresis, the gel was stained with Coomassie Brilliant Blue R--250 for more than 4h, decolored for 4--8h, and then imaged using the Bio-Rad GelDoc XR Gel Imaging System. Quantity One image analysis software was employed to determine the relative content of protein bands of OprD~2~. Statistically significant differences between the IMP^S^ and IMP^R^ were analyzed with a *t*-test using the statistics software SPSS 13.0, with *P*\<0.05 considered statistically significant.

Results {#sec013}
=======

Antimicrobial susceptibility test {#sec014}
---------------------------------

The susceptibility of the 141 *P*. *aeruginosa* strains to the 14 antimicrobial drugs tested is shown in [Table 1](#pone.0139995.t001){ref-type="table"}. Three types of strains were categorized according to their resistance to imipenem and meropenem: IMP^R^MEM^R^ (94/141) was predominant and accounted for 66.7%, IMP^R^MEM^S^ accounted for 32.6% (46/141), and only a single IMP^S^MEM^R^ strain was detected and accounted for only 0.7% (1/141).

10.1371/journal.pone.0139995.t001

###### Resistance of 141 *Pseudomonas aeruginosa* strains to 14 antimicrobial drugs, minimum inhibitory concentration (MIC, mg/L).

![](pone.0139995.t001){#pone.0139995.t001g}

  Antibacterial drugs                                             *Pseudomonas aeruginosa* (141 strains)                             
  --------------------------------------------------------------- ---------------------------------------- ----- ----- ------ ------ ------
  Imipenem                                                        1--\>128                                 16    32    0.7    0      99.3
  Meropenem                                                       2--\>128                                 16    32    32.6   0      67.4
  Gentamycin                                                      0.25--\>128                              128   128   6.4    0      93.6
  Amikacin                                                        0.06--\>128                              64    128   45.4   0      54.6
  Ciprofloxacin                                                   0.125--\>128                             4     32    10.7   11.8   77.5
  Levofloxacin                                                    0.25--128                                4     32    16.4   7.1    76.5
  Piperacillin                                                    0.06--\>128                              128   128   46.1   0      53.9
  Cefotaximes                                                     0.06--\>128                              128   128   22.7   16.3   61.0
  Cefepime                                                        0.06--\>128                              16    128   27.7   26.2   46.1
  Cefoperazone                                                    0.06--\>128                              128   128   4.9    14.2   80.9
  Cefoperazone/sulbactam [\*](#t001fn001){ref-type="table-fn"}    0.5--\>128                               64    128   17.0   22.7   60.3
  Piperacillin/tazobactam [\*](#t001fn001){ref-type="table-fn"}   2--\>128                                 128   128   29.1   0      70.9
  Aztreonam                                                       1--\>128                                 128   128   16.4   10.6   73.0
  Polymyxin B                                                     0.06--4                                  2     2     100    0      0

\*Concentration of piperacillin and cefoperazone, respectively.

PCR amplification of OprD~2~-encoding gene sequence {#sec015}
---------------------------------------------------

PCR amplification of the OprD~2~-encoding genes of the 141 CRPA strains showed negative gene amplification in 34 strains ([Fig 1](#pone.0139995.g001){ref-type="fig"}), proving that there were large fragment deletions of OprD~2~, while PCR amplification results were positive in the other 107 strains ([Table 2](#pone.0139995.t002){ref-type="table"}). Six of the positive strains showed PCR amplification fragments larger than the expected 1332bp, and sequencing analysis revealed that the OprD~2~-encoding genes contained a fragment insert (IS 852bp). The amplified products of 96 IMP^R^ strains were missing small fragments in the OprD~2~-encoding gene sequence or contained multi-point mutations in different locations. The OprD~2~-encoding gene of 4 strains was identified to be encoding for VIM--2 type metallo-β-lactamases, and in the single 1 IMP^S^MEM^R^ strain nothing unusual was observed.

![PCR amplification of the OprD~2~ gene shown for 10 selected *P*. *aeruginosa* strains.\
The electrophoresis results of strains 1, 2, 5, and 8 were negative, demonstrating that those strains had large fragment deletions. Strains 3, 4, 6, 7, 9, and 10 were positive, without any OprD~2~ gene mutations, lack of small fragments, or inserted fragments. M: Marker DL2000.](pone.0139995.g001){#pone.0139995.g001}

10.1371/journal.pone.0139995.t002

###### OprD~2~ gene sequencing results of 141 CRPA strains.

![](pone.0139995.t002){#pone.0139995.t002g}

  Modification                                 No. of strains
  -------------------------------------------- ----------------
  Large segment missing                        34
  Inserted sequence                            6
  Small pieces lacking or multiple mutations   96
  Normal sequence                              5
  Total                                        141

Analysis of the outer membrane protein OprD~2~ {#sec016}
----------------------------------------------

Changes in the outer membrane protein OprD~2~ were assessed by SDS-PAGE in 15 IMP^R^ *P*. *aeruginosa* strains with small or large fragment deletions or inserted genes and in 3 IMP^S^ *P*. *aeruginosa* strains (including the control strains PAO1). The 15 IMP^R^ strains showed an OprD~2~ protein of diminished size. In contrast, both IMP^S^ strains and the PAO1 control strain showed the expected OprD~2~ protein band at 46kDa ([Fig 2](#pone.0139995.g002){ref-type="fig"}). The protein bands for the analyzed 18 *P*. *aeruginosa* strains were quantified by gel imaging analysis ([Table 3](#pone.0139995.t003){ref-type="table"}). The 15 IMP^R^ strains yielded an average quantitative result of 10.01, while the 3 IMP^S^ strains had a value of 17.17. Significant differences in the 46-kDa OprD~2~ protein between the two groups were determined with the sensitive mean *t-*test (*P* \< 0.05).

![SDS-PAGE for the OprD~2~ protein in *Pseudomonas aeruginosa* strains.\
M = standard marker protein, lane 1--3 = IMP^R^MEM^R^ strains, lane 4--5 = IMP^R^MEM^S^ strains, lane 6 = IMP^S^MEM^R^ strains, lane 7 = for IMP^S^MEM^S^ strains, 8 = PAO1. The expected band size of 46 kDa was detected for the OprD~2~ protein in the two IMP^S^ strains and the PAO1 strain (6--8), while the size decreased in the IMP^R^ strains 1--5.](pone.0139995.g002){#pone.0139995.g002}

10.1371/journal.pone.0139995.t003

###### OprD~2~ outer membrane protein quantification in 18 *P*. *aeruginosa* strains.

![](pone.0139995.t003){#pone.0139995.t003g}

       OprD~2~-encoding genetic strain [\* \*](#t003fn002){ref-type="table-fn"}             Drug-resistant phenotype                                                               
  ---- -------------------------------------------------------------------------- ---- ---- -------------------------- ------ ------------------------------------------------ --- ---
  1    \+                                                                         \-   \-   \-                         10.8   10.01[^\#^](#t003fn003){ref-type="table-fn"}     R   R
  2    \-                                                                         \+   \-   \-                         10.2                                                    R   R
  3    \-                                                                         \+   \-   \-                         9.8                                                     R   R
  4    \-                                                                         \+   \-   \-                         9.6                                                     R   R
  5    \-                                                                         \+   \-   \-                         10.3                                                    R   R
  6    \-                                                                         \+   \-   \-                         10.5                                                    R   R
  7    \+                                                                         \-   \-   \-                         8.9                                                     R   R
  8    \-                                                                         \+   \-   \-                         9.1                                                     R   R
  9    \+                                                                         \-   \-   \-                         9.5                                                     R   R
  10   \-                                                                         \+   \-   \-                         10.2                                                    R   R
  11   \-                                                                         \+   \-   \-                         11.1                                                    R   S
  12   \-                                                                         \+   \-   \-                         10.5                                                    R   S
  13   \-                                                                         \+   \-   \-                         10.1                                                    R   S
  14   \-                                                                         \+   \-   \-                         9.8                                                     R   S
  15   \-                                                                         \+   \-   \-                         9.8                                                     R   S
  16   \-                                                                         \-   \-   \+                         17.5   17.17[^\#\#^](#t003fn004){ref-type="table-fn"}   S   R
  17   \-                                                                         \-   \-   \+                         16.8                                                    S   S
  18   \-                                                                         \-   \-   \+                         17.2                                                    S   S

\* Determined using Quantity One image analysis software.

\* \*+fragment missing or inserted, -normal sequence.

^\#^ The mean value of strains 1∼15.

^\#\#^ The mean value of strains 16--18.

Discussion {#sec017}
==========

The increasing prevalence of health care-associated infections caused by multidrug resistant *P*. *aeruginosa* (MDR-PA) is severely compromising the selection of appropriate treatments and is associated with high morbidity and mortality\[[@pone.0139995.ref013]\]. The 141 strains of *P*. *aeruginosa* analyzed in the present study were all strains with multiple drug resistance, with 19 (13.5%) of them being pan drug-resistant *P*. *aeruginosa* (PDR-PA\[[@pone.0139995.ref014]\]) strains. The availability of reliable antibiotics for patients infected with MDR-PA or PDR-PA is limited, especially for immunocompromised patients or those with underlying diseases. Drug resistance mechanisms should be elucidated and resistance surveillance needs to be strengthened in order to appropriately guide treatment choice and the clinical use of antibiotics.

OprD is a substrate-specific outer membrane porin of *P*. *aeruginosa*, and its loss can significantly reduce the susceptibility of the bacterium to carbapenems \[[@pone.0139995.ref015]\].Mutations in the OprD~2~-encoding genes lead to decreased expression or loss of the OprD~2~protein. The types of mutations are diverse and include multipoint mutations, gene deletion, frame shift mutations, and base replacement of large fragments\[[@pone.0139995.ref016]\]. Yoneyama et al. \[[@pone.0139995.ref010]\] reported two types of mutations in OprD~2~-encoding genes. The first type contains a small 11-bp deletion, causing a frameshift mutation and generating a premature termination that leads to an abnormal OprD~2~ peptide chain and the development of drug resistance. The other type of mutation was a large deletion encompassing the region from -519 to 685 (1024bp missing) across the promoter region; this mutant gene cannot be transcribed into mRNA, causing a loss of the OprD~2~ protein. The PCR amplification of the 141 clinical isolates in our study showed significant variation in the OprD~2~ gene, and the gene mutant site was different from the two deletion mutation types reported by Yoneyama. Negative PCR results were obtained for 34 strains, suggesting that the OprD~2~ gene in these strains had large fragment deletions. The other 107 strains were PCR-positive for the OprD~2~ gene, of which six strains contained an insert of 852bp, yielding PCR amplification of fragments larger than the expected 1332bp, which differed from previous results that had been obtained in our laboratory and in other studies that demonstrated OprD~2~ genetic variation with the absence or mutation of main fragment types. OprD~2~ gene expression in the four strains expressing metallo-β-lactamase genes and in the imipenem-sensitive (meropenem-resistant) strain was found to be normal. In the remaining 96 resistant strains, the OprD~2~- encoding gene sequence analysis revealed the lack of small fragments or multi-point mutation in different locations.

The outer membrane protein of *P*. *aeruginosa* is semi-permeable and can be considered as a molecular sieve that allows the passage of hydrophilic small molecular weight material \[[@pone.0139995.ref017]\]. Carbapenems as a class of small molecular weight hydrophilic β-lactam antibiotics can permeate through bacterial outer membrane porin proteins OprC, OprD~2~, and OprE, but OprD~2~ is the channel specific protein for imipenem\[[@pone.0139995.ref018]\]. For further study of the imipenem-resistance mechanisms in *P*. *aeruginosa*, we used SDS-PAGE of 18 *P*. *aeruginosa* outer membrane proteins. The results showed that the 2 IMP^S^ strains (of which one is the MEM^R^ strain) and the control strain PAO1 did not lack the outer membrane protein OprD~2~, while the 15 IMP^R^ strains exhibited a loss or decrease of OprD~2~. Gel imaging for further quantitative analysis showed that the level of the outer membrane protein OprD~2~ was significantly lower in drug-resistant strains than in the susceptible ones, with *t-* tests in both groups indicating statistically significant differences between the two groups (*P*\< 0.05). These results suggest that a loss or reduction in OprD~2~ may be the primary mechanism for imipenem-resistance in *P*. *aeruginosa*. Analysis of the OprD~2~-encoding gene sequence identified large fragment deletions in 3 of the 15 strains with a loss or decrease of OprD~2~, while the remaining 12 strains featured missing or small fragments of multi-point mutations in different locations, suggesting that OprD~2~ gene deletion may be the molecular basis for the loss of OprD~2~.

To date, several types of carbapenem-resistance mechanisms have been reported, including efflux pump overexpression, production of metallo-β-lactamases, and mutational inactivation of the outer membrane protein OprD\[[@pone.0139995.ref019],[@pone.0139995.ref020],[@pone.0139995.ref021]\]. In this study, 96.5% (136/141) of the CRPA strains showed loss or insertion of the OprD~2~-encoding gene, resulting in the absence or reduction of OprD~2~ protein expression. Of the 141 CRPA strains analyzed, 99.3% were resistant to imipenem, and 33% were sensitive to meropenem. Among them was one IMP^S^MEM^R^ strain with no abnormal expression of OprD~2~, demonstrating that the OprD~2~ change in *P*. *aeruginosa* was the main reason for bacterial resistance to imipenem, which is consistent with the related literature\[[@pone.0139995.ref006]\].

In a previous study, the resistance of 141 CRPA strains to carbapenemases was studied, and only 4 strains were found to produce the metal-producing VIM--2 enzyme, as determined using the imipenem/EDTA combined disc test (MBL-CD) and the imipenem/EDTA Etest (MBL-Etest)\[[@pone.0139995.ref022]\]. However, no Oprd~2~ protein deficiency was detected in the 4 strains, which suggests that due to its ability to produce metallo-β-lactamase, *P*. *aeruginosa* can acquire resistance to the two drugs at the same time. However, the detection rate of metallo-β-lactamase was found to be very low. Therefore, the absence of the outer membrane protein OprD~2~ in *P*. *aeruginosa* may be the main reason for the carbapenem resistance.

In conclusion, 96.5% (136/141) of the 141 CRPA strains analyzed showed a loss or insertion of the OprD~2~ encoding gene, 4 strains produced metallo-β-lactamases, and in the IMP^S^MEM^R^ strain, the resistance mechanism was apparently not linked to OprD~2~ and was caused by another mechanism. In conclusion, the main mechanism for CRPA is putatively connected with the OprD~2~ protein; analysis of more CRPA isolates is required to confirm this association.
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